TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/14/22 16:51 | 11/10/22 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schiff Andrew N | PA | D | S.m | -920 | 17.05 | 0 | -54 | -11 | 434 | I | |||||||||||||||
10/26/22 19:09 | 10/24/22 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schiff Andrew N | PA | D | S.m | -700 | 17.01 | 0 | -41 | -8 | 488 | I | |||||||||||||||
10/19/22 16:49 | 10/17/22 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schiff Andrew N | PA | D | S.m | -862 | 16.57 | 0 | -52 | -9 | 530 | I | |||||||||||||||
10/11/22 16:35 | 10/7/22 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schiff Andrew N | PA | D | S | -118 | 16.16 | 0 | -7 | -1 | 582 | I | |||||||||||||||
10/6/22 17:58 | 10/4/22 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schiff Andrew N | PA | D | S.m | -749 | 16.45 | 0 | -46 | -7 | 589 | I | |||||||||||||||
6/21/22 16:57 | 6/17/22 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schiff Andrew N | PA | D | S | -296 | 15.14 | 0 | -20 | -3 | 634 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |